Novel CGM algorithm- based glucose predictions have the potential to offer significant benefits in daily diabetes management.
Study assessing the characteristics of hypoglycemic events in T1DM patients on MDI therapy using a modern CGM system.
Paired to a wearable 14-day disposable sensor, two integrated mobile apps provide CGM data views, glucose predictions and pattern detection.
Consistent performance of glucose predictive functions shows potential for real-world efficacy in people with type 1 and type 2 diabetes on different insulin therapies.
The Accu-Chek® SmartGuide CGM solution showed strong performance, with accuracy over the entire measurement range and sensor wear time.
Accu-Chek® SmartGuide Predict app offers AI-trained algorithms designed to predict the risk of hypoglycemia.
Advanced glucose predictions have the potential to overcome current unmet needs.
Use of the Night Low Predict feature is associated with lower odds of nocturnal hypoglycemia in people with diabetes.
Advanced glucose predictions help with enabling preventive actions to improve glycemic control.